Theravance Biopharma
TBPH
TBPH
98 hedge funds and large institutions have $1.4B invested in Theravance Biopharma in 2016 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 16 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 22
2% less funds holding
Funds holding: 100 → 98 (-2)
Holders
98
Holding in Top 10
4
Calls
$1.8M
Puts
$744K
Top Buyers
| 1 | +$61.3M | |
| 2 | +$49M | |
| 3 | +$35.1M | |
| 4 |
First Manhattan
New York
|
+$25.4M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$12.4M |
Top Sellers
| 1 | -$6.92M | |
| 2 | -$4.14M | |
| 3 | -$2.96M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$2.21M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$2.07M |